Health: Public Affairs & Public Relations Support
Brevia Health provides straightforward public affairs and communications advice and support to organisations operating in the highly regulated UK healthcare sector. The consultancy brings together experts who have held senior roles in NICE, MHRA, Government Health teams, Opposition Health teams and across industry. We use this rounded perspective to bring new thinking and well-developed proposals across a wide range of policy areas.
As the UK emerges from the far-reaching consequences of COVID-19 and BREXIT, it is clear that the healthcare system has changed, and leaders are open to new approaches. Never has there been a better time for organisations to make practical, thought-through proposals which show broad-based benefits.
The much anticipated publication of the NHS Commercial Framework for New Medicines in 2021 represents a significant milestone for the pharmaceutical industry. It outlines the purpose and principles on which NHS commercial medicines activity will be based, defines the roles and responsibilities of those involved in commercial medicines activity and details how pharmaceutical companies can engage with the NHS.
Brevia Health supports global multi-nationals, innovative start-ups, providers, and charities. Our experience includes supporting companies to win IT contracts with the NHS through to gaining approval for medicines with NICE. We have also worked in areas such as in vitro diagnostics, medical devices, and genomics, as well as delivering programmes involving policy and stakeholder research, political and media monitoring, stakeholder engagement, event management, media relations, Party Conferences, and Select Committee training.
MEET THE TEAM
CLIENT EXPERIENCE
TESTIMONIALS
NEWS
10 key events in energy in 2025
As a year marked by long-anticipated decisions and significant policy signals draws to a close, Brevia Energy takes a look back at developments and decisions that shaped the UK energy landscape in 2025.
Nuclear Regulatory Taskforce Report – Key Takeaways
Last month, the Nuclear Regulatory Taskforce published its final report. Although the UK is one of 33 countries pledging to triple its nuclear capacity by 2050, the Taskforce warns that the current system risks slowing delivery at a time when global competitors are accelerating. Brevia Energy explores the key takeaways from the Report.
Who is the new CEO of the National Institute for Care and Excellence?
On 16 December 2025, the National Institute for Care and Excellence (NICE) announced that Professor Jonathan Benger CBE will be the organisation’s next Chief Executive, from Friday 19 December 2025. Professor Benger takes up his new role at a pivotal moment, as NICE plays a central part in delivering the Government’s 10 Year Health Plan for the NHS.
WORK WITH US
A track record in delivering results
Brevia Health delivers tailored support to businesses and charities operating in the health sector. Our three-step process offers a straightforward approach to delivering crucial intelligence, strategic advice and stakeholder engagement.